Published in J Gynecol Obstet Biol Reprod (Paris) on January 01, 1996
Dilated cardiomyopathy and neonatal lethality in mutant mice lacking manganese superoxide dismutase. Nat Genet (1995) 7.17
Analysis of 1.9 Mb of contiguous sequence from chromosome 4 of Arabidopsis thaliana. Nature (1998) 5.91
Alcohol, tobacco and breast cancer--collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease. Br J Cancer (2002) 5.83
Sequence and analysis of chromosome 4 of the plant Arabidopsis thaliana. Nature (1999) 5.03
Fluoxetine in the treatment of premenstrual dysphoria. Canadian Fluoxetine/Premenstrual Dysphoria Collaborative Study Group. N Engl J Med (1995) 3.92
Canadian normative data for the SF-36 health survey. Canadian Multicentre Osteoporosis Study Research Group. CMAJ (2000) 3.77
Treatment of cutaneous T-cell lymphoma by extracorporeal photochemotherapy. Preliminary results. N Engl J Med (1987) 3.13
Incidence and main causes of infertility in a resident population (1,850,000) of three French regions (1988-1989). Hum Reprod (1991) 2.98
DNA polymerase alpha inhibition by aphidicolin induces gaps and breaks at common fragile sites in human chromosomes. Hum Genet (1984) 2.92
Major vascular injuries during gynecologic laparoscopy. J Am Coll Surg (1997) 2.50
First direct observation of a nearly ideal graphene band structure. Phys Rev Lett (2009) 2.41
Estimation of the prevalence of low bone density in Canadian women and men using a population-specific DXA reference standard: the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2000) 2.40
The influence of osteoporotic fractures on health-related quality of life in community-dwelling men and women across Canada. Osteoporos Int (2001) 2.32
Extracorporeal photopheresis in the treatment of AIDS-related complex: a pilot study. Ann Intern Med (1990) 2.08
Myosin conformational states determined by single fluorophore polarization. Proc Natl Acad Sci U S A (1998) 2.07
[Surgical treatment for endometrial adenocarcinoma: first approaches. Review of the literature]. Gynecol Obstet Fertil (2003) 2.02
Amino-acid sequence of equine renal metallothionein-1B. Proc Natl Acad Sci U S A (1976) 1.99
Why multilayer graphene on 4H-SiC(0001[over ]) behaves like a single sheet of graphene. Phys Rev Lett (2008) 1.92
Treatment of erythrodermic cutaneous T-cell lymphoma with extracorporeal photochemotherapy. J Am Acad Dermatol (1992) 1.75
Uterine artery embolization in the primary treatment of uterine leiomyomas: technical features and prospective follow-up with clinical and sonographic examinations in 58 patients. AJR Am J Roentgenol (2000) 1.71
Scalable templated growth of graphene nanoribbons on SiC. Nat Nanotechnol (2010) 1.66
Effect of brain-derived neurotrophic factor treatment and forced arm use on functional motor recovery after small cortical ischemia. Stroke (2004) 1.66
Long-term (4- to 6-year) outcome of Palmaz-Schatz stenting: paucity of late clinical stent-related problems. J Am Coll Cardiol (1996) 1.65
Toll-like receptor (TLR) 2 promoter and intron 2 polymorphisms are associated with increased risk for spontaneous bacterial peritonitis in liver cirrhosis. J Hepatol (2011) 1.62
Termination of mammalian rDNA replication: polar arrest of replication fork movement by transcription termination factor TTF-I. Cell (1997) 1.61
[Specific interference with development and plastid enzyme formation in higher plants by elevated growth temperature]. Z Naturforsch B (1969) 1.60
Photopheresis for the treatment of cutaneous T cell lymphoma. J Am Acad Dermatol (1990) 1.49
Pre or post-operative medical treatment with nafarelin in stage III-IV endometriosis: a French multicenter study. Eur J Obstet Gynecol Reprod Biol (1998) 1.49
Congenital diaphragmatic hernia: can prenatal ultrasonography predict outcome? Am J Obstet Gynecol (1996) 1.47
The association between osteoporotic fractures and health-related quality of life as measured by the Health Utilities Index in the Canadian Multicentre Osteoporosis Study (CaMos). Osteoporos Int (2003) 1.47
Kinetics of folding of leucine zipper domains. Biochemistry (1995) 1.47
The SCARF osteotomy for the correction of hallux valgus deformities. Foot Ankle Int (2002) 1.45
Color Doppler energy prediction of malignancy in adnexal masses using logistic regression models. Ultrasound Obstet Gynecol (2002) 1.44
Acute fulminant hepatitis after treatment with rabeprazole and terbinafine. Arch Intern Med (2001) 1.42
Does the use of low-level laser influence wound healing in chronic venous leg ulcers? J Wound Care (2005) 1.41
Risk factors for female and male infertility: results of a case-control study. Hum Reprod (1992) 1.41
[Essential thrombocythemia and pregnancy. A review of the literature]. J Gynecol Obstet Biol Reprod (Paris) (1993) 1.40
Dialysis staff influence patients in formulating their advance directives. Am J Kidney Dis (1995) 1.39
Molecular pathogenesis of Epstein-Barr virus associated posttransplant lymphomas: new insights through latent membrane protein 1 fingerprinting. Transplantation (2001) 1.39
Current status of whole-body counting as a means to detect and quantify previous exposures to radioactive materials. Whole-body Counting Working Group. Health Phys (1991) 1.39
Phospholipid methylation and phospholipase A2 activation in cytotoxicity by human natural killer cells. Proc Natl Acad Sci U S A (1981) 1.39
[Isthmic pregnancy located in a previous caesarean section scar treated with methotrexate. A case report]. Gynecol Obstet Fertil (2005) 1.38
Approaching the dirac point in high-mobility multilayer epitaxial graphene. Phys Rev Lett (2008) 1.35
25-Hydroxyvitamin D in Canadian adults: biological, environmental, and behavioral correlates. Osteoporos Int (2010) 1.34
[The partogram: a well-known tool useful for assessing quality of obstetric care]. J Gynecol Obstet Biol Reprod (Paris) (2007) 1.31
Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts. Osteoporos Int (2010) 1.27
Construction of a FRAX® model for the assessment of fracture probability in Canada and implications for treatment. Osteoporos Int (2010) 1.25
Fracture prediction and calibration of a Canadian FRAX® tool: a population-based report from CaMos. Osteoporos Int (2010) 1.24
MALDI-TOF MS Andromas strategy for the routine identification of bacteria, mycobacteria, yeasts, Aspergillus spp. and positive blood cultures. Clin Microbiol Infect (2011) 1.23
[Idiopathic granulomatous mastitis. Review of the literature illustrated by 4 cases]. J Gynecol Obstet Biol Reprod (Paris) (1999) 1.22
Inhibition of antiskin allograft immunity by infusions with syngeneic photoinactivated effector lymphocytes. J Invest Dermatol (1989) 1.21
Preoperative chemoradiotherapy versus preoperative radiotherapy in rectal cancer patients: assessment of acute toxicity and treatment compliance. Report of the 22921 randomised trial conducted by the EORTC Radiotherapy Group. Eur J Cancer (2004) 1.21
The cisternae decorating the red blood cell membrane in congenital dyserythropoietic anemia (type II) originate from the endoplasmic reticulum. Blood (1996) 1.20
Preoperative radiotherapy (RT) for rectal cancer: predictive factors of tumor downstaging and residual tumor cell density (RTCD): prognostic implications. Int J Radiat Oncol Biol Phys (1997) 1.20
Improving outcome of chemotherapy of metastatic breast cancer by docosahexaenoic acid: a phase II trial. Br J Cancer (2009) 1.19
Etiology, prognosis and management of nuchal cystic hygroma: 25 new cases and literature review. Eur J Obstet Gynecol Reprod Biol (1997) 1.18
What is the clinical benefit of preoperative chemoradiotherapy with 5FU/leucovorin for T3-4 rectal cancer in a pooled analysis of EORTC 22921 and FFCD 9203 trials: surrogacy in question? Eur J Cancer (2012) 1.17
Cryopreservation of spermatozoa: a 1996 review. Hum Reprod Update (1997) 1.17
Electronic structure of epitaxial graphene layers on SiC: effect of the substrate. Phys Rev Lett (2007) 1.16
Associations among disease conditions, bone mineral density, and prevalent vertebral deformities in men and women 50 years of age and older: cross-sectional results from the Canadian Multicentre Osteoporosis Study. J Bone Miner Res (2003) 1.16
Decreased formation of aqueous humour in insulin-dependent diabetic patients. Br J Ophthalmol (1989) 1.15
Multifaceted intervention to decrease the rate of severe postpartum haemorrhage: the PITHAGORE6 cluster-randomised controlled trial. BJOG (2010) 1.14
Selective killing of T lymphocytes by phototoxic liposomes. Proc Natl Acad Sci U S A (1987) 1.13
Community-acquired pneumonia in children due to Mycoplasma pneumoniae: diagnostic performance of a seminested 16S rDNA-PCR. Diagn Microbiol Infect Dis (2001) 1.11
Twinning following oral contraceptive discontinuation. Int J Epidemiol (1981) 1.10
Evaluation of the quality of care for severe obstetrical haemorrhage in three French regions. BJOG (2001) 1.10
Herpes encephalitis during natalizumab treatment in multiple sclerosis. Mult Scler (2011) 1.09
Dynamic structure of metallothionein. FEBS Lett (1984) 1.08
Prospective sonographic assessment of uterine artery embolization for the treatment of fibroids. Ultrasound Obstet Gynecol (2002) 1.07
Contrast enhanced magnetic resonance imaging underestimates residual disease following neoadjuvant docetaxel based chemotherapy for breast cancer. Eur J Surg Oncol (2004) 1.07
Carrier relaxation in epitaxial graphene photoexcited near the Dirac point. Phys Rev Lett (2011) 1.07
[Gynecology-obstetrics: one and indivisible]. J Gynecol Obstet Biol Reprod (Paris) (2004) 1.07
Coexpression of gonadotropic hormones and their corresponding FSH- and LH/CG-receptors in the human prostate. Prostate (1998) 1.06
[Advanced carcinoma of the oropharynx: the value of induction chemotherapy before locoregional treatment. A retrospective study of 138 cases]. Bull Cancer (1988) 1.05
In vitro release of vancomycin and tobramycin from impregnated human and bovine bone grafts. J Antimicrob Chemother (2000) 1.04
Spectroscopic, calorimetric, and kinetic demonstration of conformational adaptation in peptide-antibody recognition. Biochemistry (1995) 1.03
Interferon-induced differentiation of U937 cells. Comparison with other agents that promote differentiation of human myeloid or monocytelike cell lines. J Clin Invest (1983) 1.02
Gastrointestinal injuries during gynaecological laparoscopy. Hum Reprod (1999) 1.02
Enhancement of doxorubicin cytotoxicity by polyunsaturated fatty acids in the human breast tumor cell line MDA-MB-231: relationship to lipid peroxidation. Int J Cancer (1998) 1.02
The role of Epstein-Barr virus in neoplastic transformation. Oncology (2001) 1.02
The measurement of premenstrual mood symptoms. J Affect Disord (1999) 1.02
Evolution of blood coagulation activators and inhibitors in the healthy human fetus. Blood (1996) 1.01
Laparoscopic surgery of unicornuate uterus with rudimentary uterine horn. Hum Reprod (1999) 1.00
Landau level spectroscopy of ultrathin graphite layers. Phys Rev Lett (2006) 1.00
Characterization of the fertility of Kit haplodeficient male mice. Int J Androl (2002) 1.00
Hodgkin's disease incidence and survival in European children and adolescents (1978-1997): report from the Automated Cancer Information System project. Eur J Cancer (2006) 0.99
[Maternal-fetal Haemophilus influenzae infections]. Presse Med (1987) 0.99
Identification of the sensory/motor area and pathologic regions using ECoG coherence. Electroencephalogr Clin Neurophysiol (1998) 0.99
Phase II study of oral vinorelbine in first-line advanced breast cancer chemotherapy. J Clin Oncol (2003) 0.98
Membrane fatty acids of breast carcinoma: contribution of host fatty acids and tumor properties. Int J Cancer (1995) 0.97
A second heterozygous MDR3 nonsense mutation associated with intrahepatic cholestasis of pregnancy. J Med Genet (2003) 0.97
Effect of an alpha-linolenic acid-rich diet on rat mammary tumor growth depends on the dietary oxidative status. Nutr Cancer (2000) 0.97
Use of recombinant factor VIIa (NovoSeven) in patients with Glanzmann thrombasthenia. Semin Hematol (2001) 0.96
Port-A-Cath infections in children with cancer. Eur J Cancer (2004) 0.96
[Dosimetric evaluation of conformal radiotherapy: conformity factor]. Cancer Radiother (2000) 0.96
Everolimus as second- or third-line treatment of advanced endometrial cancer: ENDORAD, a phase II trial of GINECO. Br J Cancer (2013) 0.96